Northwestern University Robert H. Lurie Comprehensive Cancer Center — Chicago, Illinois

Northwestern University Robert H. Lurie Comprehensive Cancer Center is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Northwestern University Robert H. Lurie Comprehensive Cancer Center has participated in 9 clinical trials with 1 currently active.

Therapeutic areas: Ovarian Cancer, NSCLC, ESCC.

Sponsors: Astellas Pharma Global Development, Inc., Leap Therapeutics, Inc., Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northwestern University Robert H. Lurie Comprehensive Cancer Center?

Northwestern University Robert H. Lurie Comprehensive Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northwestern University Robert H. Lurie Comprehensive Cancer Center conducted?

Northwestern University Robert H. Lurie Comprehensive Cancer Center has 9 clinical trials on record, with 1 currently active. Their work covers Ovarian Cancer, NSCLC, ESCC.

Is Northwestern University Robert H. Lurie Comprehensive Cancer Center accredited by Crixeo Health?

Yes — Northwestern University Robert H. Lurie Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Northwestern University Robert H. Lurie Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.